Skip to content
ClinCalc Pro
Menu
Topical scalp preparation

Coal tar with salicylic acid and precipitated sulfur

A topical preparation combining coal tar, salicylic acid and precipitated sulfur, used for chronic scaling and inflammatory skin and scalp conditions such as psoriasis and seborrhoeic dermatitis.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

Coal tar provides anti-inflammatory and antiscaling action, salicylic acid is keratolytic and softens scale, and precipitated sulfur contributes mild keratolytic, antiseptic and antiseborrhoeic effects.

Prescribing in practice

  • Coal tar increases photosensitivity, so treated skin should be protected from sunlight and care taken if phototherapy is used concurrently.
  • Keep away from the eyes and avoid broken, infected or acutely inflamed skin, as the combination can cause irritation.
  • Salicylic acid is percutaneously absorbed, so avoid extensive or prolonged application, especially in children, to limit salicylate toxicity risk.

Monitoring

No laboratory monitoring is generally required; review the skin or scalp for irritation and treatment response.

Counselling the patient

  • Apply as directed and avoid contact with the eyes and healthy surrounding skin.
  • Expect a characteristic odour and possible staining of fabrics and light hair.
  • Protect treated areas from strong sunlight and stop if the skin becomes irritated.

Evidence & guidelines

Multi-ingredient coal tar, salicylic acid and sulfur preparations are long-established keratolytic-antiscaling treatments for scaling dermatoses such as psoriasis and seborrhoeic dermatitis.

Reference: Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.